Seizures affect the lives of 10% of the global population and result in epilepsy in 1 to 2% of
people around the world. Current knowledge about etiology, diagnosis, and treatments for …

Elevated cardiovascular risk including stroke, heart failure, and heart attack is present even
after normalization of blood pressure in patients with hypertension. Underlying immune cell …

Background Neurological disorders are increasingly recognised as major causes of death
and disability worldwide. The aim of this analysis from the Global Burden of Diseases …

Several studies have illustrated that transcutaneous vagus nerve stimulation (tVNS) can
elicit therapeutic effects that are similar to those produced by its invasive counterpart, vagus …

Globally, as populations age there will be challenges and opportunities to deliver optimal
health care to senior citizens. Epilepsy, a condition characterised by spontaneous recurrent …

An imbalance between excitation and inhibition has been a longstanding proposed
mechanism regarding ictogenesis and epileptogenesis. This imbalance is related to …

China has approximately 10 million people with epilepsy. There is a vast epilepsy treatment
gap in China, mainly driven by deficiencies in health-care delivery and social discrimination …

Currently available pharmacological treatment of epilepsy has limited effectiveness. In
epileptic patients, pharmacological treatment with available anticonvulsants leads to seizure …

Individuals with drug-resistant focal epilepsy are candidates for surgical treatment as a
curative option. Before surgery can take place, the patient must have a presurgical …

Status epilepticus is a life-threatening neurological emergency that affects both adults and
children. Approximately 36% of episodes of status epilepticus do not respond to the current …